Job Overview
Location
Cambridge, MA
Job Type
Full-time
Category
Product Management
Date Posted
June 19, 2026
Full Job Description
📋 Description
- • Serve as the primary operational partner for the Next Wave Program Team, ensuring timely and precise advancement of pipeline programs from translation to clinical proof-of-concept.
- • Partner directly with the Program Leader to drive cross-functional execution across R&D, clinical, regulatory, manufacturing, and commercial functions.
- • Provide operational leadership for multiple development programs at varying stages, maintaining alignment on timelines, milestones, and resource allocation.
- • Establish and maintain program-level governance structures, including meeting cadences, decision logs, and escalation pathways to ensure accountability and transparency.
- • Develop and manage program roadmaps, risk registers, and key performance indicators to track progress and proactively identify bottlenecks or deviations.
- • Coordinate cross-functional team meetings, prepare executive summaries, and communicate program status to senior leadership and stakeholders.
- • Ensure seamless integration of new pipeline initiatives into the broader organizational workflow, aligning with Scholar Rock’s proprietary platform and anti-myostatin therapeutic focus.
- • Act as a strategic thought-partner to the Program Leader, contributing to prioritization decisions, resource planning, and portfolio strategy for next-wave programs.
- • Drive consistency in program management practices across the Next Wave team, promoting standardization of processes while adapting to the unique needs of rare disease development.
- • Collaborate with Clinical Operations, Regulatory Affairs, and Medical Affairs to align trial design, patient recruitment strategies, and regulatory submission timelines.
- • Monitor external scientific and competitive landscape developments to inform program strategy and identify opportunities for innovation in neuromuscular disease treatment.
- • Maintain rigorous documentation of program decisions, changes, and outcomes in alignment with company compliance and quality standards.
- • Support the VP, Head of Program Leadership & Management in scaling program management capabilities as the pipeline expands.
- • Represent the Next Wave team in internal and external forums, ensuring clear, accurate, and compelling communication of program progress and scientific rationale.
- • Foster a culture of urgency, precision, and collaboration within the program team and across functional departments.
🎯 Requirements
- • Proven experience in program management within biopharmaceutical R&D, specifically in oncology, neurology, or rare disease therapeutic areas
- • Demonstrated ability to lead multiple concurrent development programs from early translation through clinical proof-of-concept
- • Strong track record of cross-functional leadership in matrixed organizations involving clinical, regulatory, manufacturing, and commercial teams
- • Expertise in developing and managing program roadmaps, risk registers, and governance structures
- • Experience working with proprietary biologic platforms or monoclonal antibody development
- • Excellent communication and executive presentation skills, with ability to distill complex scientific and operational data for senior leadership
🏖️ Benefits
- • Competitive salary and performance-based bonus structure
- • Comprehensive health, dental, and vision insurance
- • 401(k) plan with company match
- • Generous paid time off and parental leave policies
- • Professional development and continuing education stipend
- • Onsite wellness programs and employee assistance resources
Skills & Technologies
See exactly how your profile matches this role — strengths, skill gaps, and what to do about them.
About Scholar Rock Holding Corporation
Scholar Rock Holding Corporation is a clinical-stage biopharmaceutical company focused on discovering and developing innovative medicines targeting the latent transforming growth factor-beta (TGFβ) superfamily. The company leverages its proprietary platform to selectively modulate growth factors implicated in disease pathways, advancing therapies for neuromuscular, fibrotic, and other serious conditions. Its lead product candidate, apitegromab, is in Phase 3 trials for spinal muscular atrophy (SMA).
Subscribe to the weekly newsletter for similar remote roles and curated hiring updates.
Newsletter
Weekly remote jobs and featured talent.
No spam. Only curated remote roles and product updates. You can unsubscribe anytime.
Similar Opportunities
3 days ago
Clipboard Health Inc.
3 months ago
Nexxa s.r.l.
3 months ago
Klaviyo, Inc.
3 months ago